The national vaccination plan slated to begin this month will prioritize medical students, persons with comorbidities and frontline workers such as janitors, among others.
The Inter-Agency Task Force (IATF) had recently approved a “prioritization criteria” to aid in vaccine distribution, both at the national and local government levels, according to Palace spokesperson Harry Roque.
The list, crafted by the Interim National Immunization Technical Advisory Group and the health department’s Technical Advisory Group, classifies recipients into three classes of priority groups (A, B and C).
The table identifies who is included in which priority group.
PRIORITY GROUP A
A1: Frontline healthcare workers (national and local; private and public) Health professionals
Non-professionals (medical school students, nursing aides, janitors, barangay health workers)
A2: Senior citizens over 60 years of age
A3: Persons with comorbidities not included in preceding categories
A4: Frontline workers in essential sectors (e.g., uniformed personnel)
A5: Indigents not included in preceding categories
PRIORITY GROUP B
B1: Teachers / Social workers
B2: Other government workers (career and non-career personnel)
B3: Other essential workers
B4: Indigenous peoples Sociodemographic groups at markedly
higher risk for infection than seniors and IPs
B5: Overseas Filipino workers
B6: Remaining workforce members
PRIORITY GROUP C
Filipino population not included in other groups
Priority group A4 indicates workers in the “essentials” sector which was allowed full capacity operation during the enhanced community quarantine last March to June. These institutions included hospitals, dialysis and chemotherapy centers, other medical facilities, medicine manufacturers, agriculture, forestry and fishery industries, delivery services handling food, medicines and other essential supplies.
According to the DOH, 116,000 health workers had registered to get vaccinated, while 117,000 doses of the Pfizer vaccine is expected to arrive midmonth. Some 5 to 9 million doses of the AstraZeneca vaccine from the COVAX facility are also eyed to arrive by the second quarter.